A
Avadel Pharmaceuticals plc (AVDL)
NGM – Real vaqt narxi. Valyuta: USD
21.64
0.00 (0.00%)
Bozor ochiq: Feb 11, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
21.64
0.00 (0.00%)
Bozor ochiq: Feb 11, 2026, 4:00 PM EDT
Avadel Pharmaceuticals plc Qo'shma Shtatlarda biofarmatsevtika kompaniyasi sifatida faoliyat yuritadi. Uning asosiy mahsulot nomzodi — bu natriy oksibat formulasi bo'lgan LUMRYZ, u narkolepsiya bilan og'rigan yetti yosh va undan katta bemorlarda katapleksiya yoki haddan tashqari kunduzgi uyquchanlikni davolash uchun 3-bosqichli klinik sinovdan o'tmoqda. Kompaniya ilgari Flamel Technologies SA nomi bilan tanilgan va 2017 yil yanvar oyida Avadel Pharmaceuticals plc nomini olgan. Avadel Pharmaceuticals plc 2015 yilda tashkil etilgan va shtab-kvartirasi Dublin 2, Irlandiyada joylashgan. 2026 yil 12 fevral holatiga ko'ra, Avadel Pharmaceuticals plc Alkermes plc sho'ba korxonasi sifatida faoliyat yuritadi.
There is no data to display
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-01-20 | 8-K | tm263598d1_8k.htm |
| 2026-01-12 | 8-K | tm262904d1_8k.htm |
| 2025-12-19 | DEFA14A | tm2534012d1_defa14a.htm |
| 2025-12-18 | 8-K | tm2533819d1_8k.htm |
| 2025-12-09 | 8-K | tm2533119d1_8k.htm |
| 2025-12-03 | DEFM14A | tm2529379-3_defm14a.htm |
| 2025-12-02 | PRER14A | tm2529379-2_prer14a.htm |
| 2025-11-19 | DEFA14A | tm2529228d12_defa14a.htm |
| 2025-11-17 | DEFA14A | tm2531449d1_8k.htm |
| 2025-11-14 | DEFA14A | tm2529228d10_defa14a.htm |